| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Second Department of Pathology*
and
Gunma University School of Health Sciences,
Gunma University School of Medicine, Gunma, Japan
The p16 protein (p16) is a cyclin-dependent kinase (CDK) inhibitor that decelerates the cell cycle by inactivating the CDKs that phosphorylate retinoblastoma (Rb) protein. Recent biological studies have revealed that p16 expression is markedly influenced by the status of Rb expression, and p16 overexpression has been demonstrated in cervical cancers because of functional inactivation of Rb by human papillomavirus (HPV) E7 protein. To clarify the relationship between p16 overexpression and HPV infection in cervical carcinogenesis, immunohistochemical analysis of p16 and detection of HPV by in situ hybridization and polymerase chain reaction were performed on 139 formalin-fixed and paraffin-embedded samples of cervical and genital condylomatous and neoplastic lesions. Marked overexpression of p16 protein, ie, diffuse and strong immunostaining, was observed in all cervical cancers and preneoplastic lesions with infection by high- and intermediate-risk HPVs, ie, subtypes 16, 18, 31, 33, 52, and 58. Condylomata acuminata and low-grade squamous intraepithelial lesions with infection by low-risk HPV such as HPV-6/11 showed focal and weak immunohistochemical staining for p16. Our results clearly showed that the mode of p16 expression in lesions with high- and intermediate-risk HPVs differed from its expression in lesions with low-risk HPVs and thus might be attributable to differences in functional inactivation of Rb protein by different HPVs.
This article has been cited by other articles:
 |
|
 |
|
  R. S. Saad, N. Ismiil, V. Dube, S. Nofech-Mozes, and M. A. Khalifa CDX-2 Expression Is a Common Event in Primary Intestinal-type Endocervical Adenocarcinoma Am J Clin Pathol, October 1, 2009; 132(4): 531 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. ADAMOPOULOU, E. KALKANI, E. CHARVALOS, D. AVGOUSTIDIS, D. HAIDOPOULOS, and C. YAPIJAKIS Comparison of Cytology, Colposcopy, HPV Typing and Biomarker Analysis in Cervical Neoplasia Anticancer Res, August 1, 2009; 29(8): 3401 - 3409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. E. Salit, J. Tinmouth, S. Chong, J. Raboud, C. Diong, D. Su, M. Sano, A. Lytwyn, W. Chapman, and J. Mahony Screening for HIV-Associated Anal Cancer: Correlation of HPV Genotypes, p16, and E6 Transcripts with Anal Pathology Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 1986 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Cuschieri and N. Wentzensen Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical Neoplasia Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2536 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Aulmann, J Schleibaum, R Penzel, P Schirmacher, G Gebauer, and H P Sinn Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status J. Clin. Pathol., September 1, 2008; 61(9): 1034 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ressler, R. Scheiden, K. Dreier, A. Laich, E. Muller-Holzner, H. Pircher, D. Morandell, I. Stein, H.-P. Viertler, F. R. Santer, et al. High-risk Human Papillomavirus E7 Oncoprotein Detection in Cervical Squamous Cell Carcinoma Clin. Cancer Res., December 1, 2007; 13(23): 7067 - 7072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N Kalof and K. Cooper Our approach to squamous intraepithelial lesions of the uterine cervix J. Clin. Pathol., May 1, 2007; 60(5): 449 - 455. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shai, T. Brake, C. Somoza, and P. F. Lambert The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities Cancer Res., February 15, 2007; 67(4): 1626 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J P A Baak, A-J Kruse, S J Robboy, E A M Janssen, B van Diermen, and I Skaland Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers J. Clin. Pathol., October 1, 2006; 59(10): 1017 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fiedler, S. Ressler, B. Campo-Fernandez, A. Laich, L. Jansen, A. Widschwendter, H.-P. Viertler, N. Bacher, D. Morandell, E. Muller-Holzner, et al. Expression of the high-risk human papillomavirus type 18 and 45 E7 oncoproteins in cervical carcinoma biopsies J. Gen. Virol., December 1, 2005; 86(12): 3235 - 3241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Bravaccini, M A Sanchini, A Amadori, L Medri, L Saragoni, D Calistri, F Monti, A Volpi, and D Amadori Potential of telomerase expression and activity in cervical specimens as a diagnostic tool J. Clin. Pathol., September 1, 2005; 58(9): 911 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Murphy, M Ring, C C B B Heffron, B King, A G Killalea, C Hughes, C M Martin, E McGuinness, O Sheils, and J J O'Leary p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer J. Clin. Pathol., May 1, 2005; 58(5): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C.M. Guimaraes, M. A. G. Goncalves, C. P. Soares, J. S.R. Bettini, R. A. Duarte, and E. G. Soares Immunohistochemical Expression of p16INK4a and bcl-2 According to HPV Type and to the Progression of Cervical Squamous Intraepithelial Lesions J. Histochem. Cytochem., April 1, 2005; 53(4): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wang, M. Trunk, M. Schiffman, R. Herrero, M. E. Sherman, R. D. Burk, A. Hildesheim, M. C. Bratti, T. Wright, A. C. Rodriguez, et al. Validation of p16INK4a as a Marker of Oncogenic Human Papillomavirus Infection in Cervical Biopsies from a Population-Based Cohort in Costa Rica Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1355 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Wang, B.-Y. Zheng, X.-D. Li, T. Angstrom, M. S. Lindstrom, and K.-L. Wallin Predictive Significance of the Alterations of p16INK4A, p14ARF, p53, and Proliferating Cell Nuclear Antigen Expression in the Progression of Cervical Cancer Clin. Cancer Res., April 1, 2004; 10(7): 2407 - 2414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Begum, M. L. Gillison, M. A. Ansari-Lari, K. Shah, and W. H. Westra Detection of Human Papillomavirus in Cervical Lymph Nodes: A Highly Effective Strategy for Localizing Site of Tumor Origin Clin. Cancer Res., December 15, 2003; 9(17): 6469 - 6475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Brake, J. P. Connor, D. G. Petereit, and P. F. Lambert Comparative Analysis of Cervical Cancer in Women and in a Human Papillomavirus-Transgenic Mouse Model: Identification of Minichromosome Maintenance Protein 7 as an Informative Biomarker for Human Cervical Cancer Cancer Res., December 1, 2003; 63(23): 8173 - 8180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Middleton, W. Peh, S. Southern, H. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, et al. Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers J. Virol., October 1, 2003; 77(19): 10186 - 10201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Natarajan, M. Saeb, C. P. Crum, S. B. Woo, P. H. McKee, and J. G. Rheinwald Co-Expression of p16INK4A and Laminin 5 {gamma}2 by Microinvasive and Superficial Squamous Cell Carcinomas in Vivo and by Migrating Wound and Senescent Keratinocytes in Culture Am. J. Pathol., August 1, 2003; 163(2): 477 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Acs, P. J. Zhang, C. M. McGrath, P. Acs, J. McBroom, A. Mohyeldin, S. Liu, H. Lu, and A. Verma Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression Am. J. Pathol., June 1, 2003; 162(6): 1789 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Klussmann, E. Gultekin, S. J. Weissenborn, U. Wieland, V. Dries, H. P. Dienes, H. E. Eckel, H. J. Pfister, and P. G. Fuchs Expression of p16 Protein Identifies a Distinct Entity of Tonsillar Carcinomas Associated with Human Papillomavirus Am. J. Pathol., March 1, 2003; 162(3): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N Murphy, M Ring, A G Killalea, V Uhlmann, M O'Donovan, F Mulcahy, M Turner, E McGuinness, M Griffin, C Martin, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrepTM smears J. Clin. Pathol., January 1, 2003; 56(1): 56 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. z. Hausen Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis J Natl Cancer Inst, May 3, 2000; 92(9): 690 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kazianis, L. D. Coletta, D. C. Morizot, D. A. Johnston, E. A. Osterndorff, and R. S. Nairn Overexpression of a fish CDKN2 gene in a hereditary melanoma model Carcinogenesis, April 1, 2000; 21(4): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
